The blistering rally in Hims & Hers Health Inc. that’s captivated meme-stock traders has ground to a halt, setting up a ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

The shortages were declared in August 2022. Meanwhile, Axios reports on how makers of copycat weight loss drugs are preparing for a crackdown. In medical tech and pharma news: a pacemaker recall, the ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye co ...

Makers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food ...

New rules were announced earlier this month over online pharmacies which are prescribing the drugs as 500,000 Britons aid to ...

Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so ...

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...

Nicole started Wegovy when she was unable to obtain Ozempic amid the shortage of the drug, which is used for diabetes. But the 51-year-old has also experienced a plateau in weight loss.

Wegovy is the first GLP-1 medication for weight loss to gain approval from the Food and Drug Administration (FDA). The organization approved it in 2021. However, there are strict eligibility ...